KLSE (MYR): GENETEC (0104)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
1.00
Today's Change
-0.02 (1.96%)
Day's Change
0.99 - 1.06
Trading Volume
30,552,500
Market Cap
777 Million
NOSH
777 Million
Latest Quarter
30-Jun-2024 [#0]
Announcement Date
29-Aug-2024
Next Quarter
30-Sep-2024
Est. Ann. Date
28-Nov-2024
Est. Ann. Due Date
29-Nov-2024
QoQ | YoY
-39.69% | -41.55%
Revenue | NP to SH
271,301.000 | 68,742.000
RPS | P/RPS
34.93 Cent | 2.86
EPS | P/E | EY
8.85 Cent | 11.30 | 8.85%
DPS | DY | Payout %
1.98 Cent | 1.98% | 22.40%
NAPS | P/NAPS
0.62 | 1.60
QoQ | YoY
-9.51% | -4.9%
NP Margin | ROE
24.24% | 14.17%
F.Y. | Ann. Date
30-Jun-2024 | 29-Aug-2024
Latest Audited Result
31-Mar-2023
Announcement Date
31-Jul-2023
Next Audited Result
31-Mar-2024
Est. Ann. Date
31-Jul-2024
Est. Ann. Due Date
27-Sep-2024
Revenue | NP to SH
347,003.000 | 86,123.000
RPS | P/RPS
44.68 Cent | 2.24
EPS | P/E | EY
11.09 Cent | 9.02 | 11.09%
DPS | DY | Payout %
1.98 Cent | 1.98% | 17.88%
NAPS | P/NAPS
0.62 | 1.60
YoY
null%
NP Margin | ROE
24.37% | 17.75%
F.Y. | Ann. Date
30-Jun-2024 | 29-Aug-2024
Revenue | NP to SH
347,003.000 | 86,123.000
RPS | P/RPS
44.68 Cent | 2.24
EPS | P/E | EY
11.09 Cent | 9.02 | 11.09%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
3.92% | 23.88%
NP Margin | ROE
24.37% | 17.75%
F.Y. | Ann. Date
30-Jun-2024 | 29-Aug-2024
Last 10 FY Result | ||||||||||||||
AQR | T4Q | 30/06/24 | 30/06/23 | 31/03/23 | 31/03/22 | 31/03/21 | 31/03/20 | 31/03/19 | 31/03/18 | 31/03/17 | 31/03/16 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 347,003 | 271,301 | 347,003 | 0 | 307,409 | 223,559 | 97,078 | 80,332 | 97,159 | 101,028 | 70,627 | 129,003 | 12.73% | |
PBT | 90,390 | 70,602 | 90,390 | 0 | 80,299 | 62,294 | -4,825 | -1,322 | 4,219 | 5,893 | -3,578 | 8,266 | 33.61% | |
Tax | -5,841 | -4,841 | -5,841 | 0 | -5,645 | -4,158 | 439 | 422 | 1,771 | -893 | -58 | -1,472 | 18.17% | |
NP | 84,549 | 65,761 | 84,549 | 0 | 74,654 | 58,136 | -4,386 | -900 | 5,990 | 5,000 | -3,636 | 6,794 | 35.72% | |
- | ||||||||||||||
NP to SH | 86,123 | 68,742 | 86,123 | 0 | 73,400 | 56,400 | -4,246 | -166 | 5,613 | 3,544 | -4,027 | 4,406 | 43.35% | |
- | ||||||||||||||
Tax Rate | 6.46% | 6.86% | 6.46% | - | 7.03% | 6.67% | - | - | -41.98% | 15.15% | - | 17.81% | - | |
Total Cost | 262,454 | 205,540 | 262,454 | 0 | 232,755 | 165,423 | 101,464 | 81,232 | 91,169 | 96,028 | 74,263 | 122,209 | 9.70% | |
- | ||||||||||||||
Net Worth | 485,065 | 485,065 | 485,065 | 365,857 | 372,760 | 149,794 | 74,174 | 74,862 | 72,715 | 63,000 | 57,676 | 62,179 | 28.25% |
Equity | ||||||||||||||
AQR | T4Q | 30/06/24 | 30/06/23 | 31/03/23 | 31/03/22 | 31/03/21 | 31/03/20 | 31/03/19 | 31/03/18 | 31/03/17 | 31/03/16 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Worth | 485,065 | 485,065 | 485,065 | 365,857 | 372,760 | 149,794 | 74,174 | 74,862 | 72,715 | 63,000 | 57,676 | 62,179 | 28.25% | |
NOSH | 776,650 | 776,650 | 776,650 | 690,297 | 750,157 | 681,961 | 45,639 | 42,361 | 42,265 | 39,220 | 35,168 | 351,206 | 10.09% |
Ratio Analysis | ||||||||||||||
AQR | T4Q | 30/06/24 | 30/06/23 | 31/03/23 | 31/03/22 | 31/03/21 | 31/03/20 | 31/03/19 | 31/03/18 | 31/03/17 | 31/03/16 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NP Margin | 24.37% | 24.24% | 24.37% | 0.00% | 24.28% | 26.00% | -4.52% | -1.12% | 6.17% | 4.95% | -5.15% | 5.27% | - | |
ROE | 17.75% | 14.17% | 17.75% | 0.00% | 19.69% | 37.65% | -5.72% | -0.22% | 7.72% | 5.63% | -6.98% | 7.09% | - |
Per Share | ||||||||||||||
AQR | T4Q | 30/06/24 | 30/06/23 | 31/03/23 | 31/03/22 | 31/03/21 | 31/03/20 | 31/03/19 | 31/03/18 | 31/03/17 | 31/03/16 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RPS | 45.07 | 35.24 | 45.07 | 0.00 | 44.53 | 32.83 | 222.49 | 189.93 | 239.17 | 280.63 | 200.82 | 367.22 | -22.44% | |
EPS | 11.19 | 8.93 | 11.19 | 0.00 | 10.63 | 8.28 | -9.73 | -0.39 | 13.82 | 9.84 | -11.45 | 12.53 | -1.36% | |
DPS | 2.00 | 2.00 | 2.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | |
NAPS | 0.63 | 0.63 | 0.63 | 0.53 | 0.54 | 0.22 | 1.70 | 1.77 | 1.79 | 1.75 | 1.64 | 1.77 | -11.76% |
Adjusted Per Share Value based on latest NOSH - 776,650 | ||||||||||||||
AQR | T4Q | 30/06/24 | 30/06/23 | 31/03/23 | 31/03/22 | 31/03/21 | 31/03/20 | 31/03/19 | 31/03/18 | 31/03/17 | 31/03/16 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RPS | 44.68 | 34.93 | 44.68 | 0.00 | 39.58 | 28.79 | 12.50 | 10.34 | 12.51 | 13.01 | 9.09 | 16.61 | 12.73% | |
EPS | 11.09 | 8.85 | 11.09 | 0.00 | 9.45 | 7.26 | -0.55 | -0.02 | 0.72 | 0.46 | -0.52 | 0.57 | 43.27% | |
DPS | 1.98 | 1.98 | 1.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | |
NAPS | 0.6246 | 0.6246 | 0.6246 | 0.4711 | 0.48 | 0.1929 | 0.0955 | 0.0964 | 0.0936 | 0.0811 | 0.0743 | 0.0801 | 28.24% |
Price Multiplier on Financial Quarter End Date | ||||||||||||||
AQR | T4Q | 30/06/24 | 30/06/23 | 31/03/23 | 31/03/22 | 31/03/21 | 31/03/20 | 31/03/19 | 31/03/18 | 31/03/17 | 31/03/16 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Date | 28/06/24 | 28/06/24 | 28/06/24 | 30/06/23 | 31/03/23 | 31/03/22 | 31/03/21 | 31/03/20 | 29/03/19 | 30/03/18 | 31/03/17 | 31/03/16 | - | |
Price | 2.24 | 2.24 | 2.24 | 2.32 | 2.70 | 2.52 | 4.25 | 1.17 | 1.73 | 1.33 | 0.85 | 0.14 | - | |
P/RPS | 4.97 | 6.36 | 4.97 | 0.00 | 6.06 | 7.68 | 1.91 | 0.62 | 0.72 | 0.47 | 0.42 | 0.04 | 79.35% | |
P/EPS | 20.03 | 25.09 | 20.03 | 0.00 | 25.39 | 30.42 | -43.67 | -298.10 | 12.52 | 13.51 | -7.42 | 1.12 | 41.81% | |
EY | 4.99 | 3.99 | 4.99 | 0.00 | 3.94 | 3.29 | -2.29 | -0.34 | 7.99 | 7.40 | -13.47 | 89.59 | -29.51% | |
DY | 0.89 | 0.89 | 0.89 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | |
P/NAPS | 3.56 | 3.56 | 3.56 | 4.38 | 5.00 | 11.45 | 2.50 | 0.66 | 0.97 | 0.76 | 0.52 | 0.08 | 58.37% |
Price Multiplier on Announcement Date | ||||||||||||||
AQR | T4Q | 30/06/24 | 30/06/23 | 31/03/23 | 31/03/22 | 31/03/21 | 31/03/20 | 31/03/19 | 31/03/18 | 31/03/17 | 31/03/16 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Date | 29/08/24 | 29/08/24 | 29/08/24 | - | 31/05/23 | 26/05/22 | 25/05/21 | 24/06/20 | 28/05/19 | 22/05/18 | 24/05/17 | 24/05/16 | - | |
Price | 1.02 | 1.02 | 1.02 | 0.00 | 2.40 | 2.44 | 3.79 | 1.40 | 1.39 | 1.40 | 0.865 | 1.22 | - | |
P/RPS | 2.26 | 2.89 | 2.26 | 0.00 | 5.39 | 7.43 | 1.70 | 0.74 | 0.58 | 0.50 | 0.43 | 0.33 | 26.24% | |
P/EPS | 9.12 | 11.42 | 9.12 | 0.00 | 22.57 | 29.46 | -38.95 | -356.70 | 10.06 | 14.22 | -7.55 | 9.73 | -0.78% | |
EY | 10.97 | 8.75 | 10.97 | 0.00 | 4.43 | 3.39 | -2.57 | -0.28 | 9.94 | 7.03 | -13.24 | 10.28 | 0.79% | |
DY | 1.96 | 1.96 | 1.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | |
P/NAPS | 1.62 | 1.62 | 1.62 | 0.00 | 4.44 | 11.09 | 2.23 | 0.79 | 0.78 | 0.80 | 0.53 | 0.69 | 10.89% |
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
Serba Dinamik in the making for a technology stock... hopefully they too not cooking the book....
2 days ago
nearly all Co. cooked Books, whether it is 80%, 60, 40 or Serba's ways fully cooked
2 days ago
Genetec Technology Bhd faces investor concerns. Shares have plummeted due to potential delays in new orders, policy uncertainties, and concerns about upcoming results. The company's market value has decreased significantly. CIMB Securities has downgraded the stock and lowered its target price.
https://theedgemalaysia.com/node/723965
2 days ago
You lose until sot jor? Sour grape you from 1.80 average down all the way to 1.00?????
1 day ago
Jadi Penny?
Hahaha.. dont dream and drive lah.
Wont be penny stock. Going push up from today.
Dream and keep dream those want RM1 below.
Kikikiki
1 day ago
Wait lah 80 sen.
If hit i wont be here anymore =_
1 black horse coming. Wait you at RM1.20 to RM1.50
Lets fly RM1.10+ first
1 day ago
Genetec's chart very nice. The dump only starts to gain volume so expect lower target price. I say 0.50 can consider
1 day ago
Kim Jong Un said yesterday,
Posted by Kim > Aug 29, 2024 4:33 PM | Report Abuse
Dont want? No cheap tomorrow
Kikiki
Kim Jong Un said Today,
Posted by Kim > Aug 30, 2024 11:22 AM | Report Abuse
Lets fly
kikikiki
Wait and dream la lower 80 sen u want. Its ok
Now i want bomb it.
NK Kim Jong Un,
U think Bursa is your father NK stock market ker…
🥸
1 day ago
CIMB Securities, one of only three research houses covering the stock, on Friday warned of a 30% decline in Genetec’s earnings for the year ending June 30, 2025 (FY2025) because of delays in new order wins from one of the automotive manufacturers adopting a more cautious approach to capacity expansion.
The research house downgraded the stock to ‘hold’ from ‘buy’ and lowered its target price to RM1.60 from RM3.70.
1 day ago
Fed Favored Inflation Gauge’s Mild Gain Sets Stage for Rate Cut
Core PCE advanced 0.2% in July, in line with expectations
Consumer spending accelerated slightly on car purchases
https://www.bloomberg.com/news/articles/2024-08-30/fed-s-preferred-inflation-metric-rises-mildly-spending-picks-up
23 hours ago
Tesla and Intel were up 3.8 percent and almost 10 percent respectively on Friday
23 hours ago
If Donald Trump win the next US presidential election genetec will go below 60c. If Kamala Harris win then you will see hope in genetec. 50/50. Place your bet
21 hours ago
Announcing dividend as a last ditch effort so that institute investors hold onto this rubbish? Hah. This company has been taking people for a ride by hyping on Tesla’s bullshit as well. Nothing lasts forever. The one client they have is struggling now that the market sees past its hype. Numbers don’t lie. The founder has been taking his profits out of this sinking ship, while story telling the market to hodl. Do your own due d and research. It’s his modus operandi given what he has done in the past. Take away that Tesla hoolabaloo and what’s left for the company? Nothing of significance. This stock ain’t worth 1/10 what it is today. Enjoy the ride!
16 hours ago
owner selling
EPF trading out
only small fry like me keep averaging
should have just cut at 1.40 instead i go average at 1.40
someone said sour? my average now 1.80, yes lost 80 cent per share i sour like chewing whole lemon
12 hours ago
Not only the managing director took the minority shareholders for a ride but he also hoodwinked all the various funds that invested in genetec. As early as Q1 he already was planning for a LTIP while CIMB was still still promoting the share with tp RM3.60 and he subtly started disposing his shares as early as Mar 2024. In the recent EGM held on 29/8/2024 the BOD approved the LTIP. Rumor has it that it'll be priced at not more than 40sen. What the MD sold assuming he sold yesterday @RM1.00, he can now buy back 2.5x the qty he disposed since early tis year at a much lower price via LTIP.
12 hours ago
If based on forward eps 6x 15pe, the fair value only 0.90 , today closing 1.00 ........ let us wait and c what will happen .
10 hours ago
genetec hit RM20.00+ when Tesla was the biggest and prima donna in the ev industry. And d sp of Tesla ATH was RM800.00 +.
Where is tesla today???
8 hours ago
The share price has crashed 74% from the high 3 years ago. Clear blood in the streets. Still a falling knife.
Question is has GENETEC business model permanently broken? If not, this could be an opportunity. I think nobody knows the real answer.
But the reward to risk payoffs look good.
So, the logical action is to bet small so that if it doesn't pan out, it doesn't matter, but if it does pan out, then , this one win will offset. The key is small constant bets in similar situations.
The risks are real, the recovery power weaker than say PBBANK or S&P500. For maximum benefits, need to hold out for at least 2-3 years after it finds bottom. Right now still no bottom yet.
I blogged about it here - https://klse.i3investor.com/web/blog/detail/DividendGuy67/2024-08-31-story-h468115071-GENETEC_Blood_on_the_Streets.
8 hours ago
boyah89
wrong. epf dump and buy also.. not dump only
2 days ago